Antananarivo, February 22, 9:05 a.m. – Next step in the process of international recognition of the more curative CVO. The improved traditional remedy proposed by the Malagasy government should pass through the laboratories of the Madagascar Medicines Agency (AgMed) in order to obtain a marketing authorization (AMM). This recommendation was made by the members of the regional advisory committee of experts on traditional medicine for the response to Covid-19 (React). A mission sent by the World Health Organization (WHO) to see the progress made by the country in the development of the curative CVO Plus.
“After taking stock of the clinical trials on the curative CVO Plus, the mission recommended that the sponsors move on to the stage of filing a complete marketing authorization application file with the Agence des drugs from Madagascar,” reads a press release from the Ministry of Public Health. According to the statement issued by the communication services of the Ministry of Public Health, this step is necessary to allow the drug to be subjected to a “multicenter study comparing curative CVO Plus to standard treatments with a new protocol”.
React members carried out their mission in Madagascar from February 14 to 18. Their arrival was welcomed by Prime Minister Christian Ntsay. The clinical trial conducted by the Big Island was included in a framework protocol developed by the WHO, the purpose of which was “to evaluate, among other things, the quality, the non-toxicity and the effectiveness of the curative CVO Plus”, can we read more in this press release. During his meeting with the committee, the Prime Minister affirmed that “WHO has already recognized the clinical trials, but other steps still need to be discussed between the national scientific committee and the WHO for the medicine to obtain recognition. full international.
Photo: Presidency of the Republic
–
